CAR T Cells: Second-Line Treatment Option for NHL? - NCI

Recent trial results suggest that CAR T cells may be superior to standard treatments for B-cell NHL that has not responded or has returned after treatment.

CAR T Therapy Fact Sheet by Brad Snyder - Issuu

Cells, Free Full-Text

Non-viral precision T cell receptor replacement for personalized cell therapy

The progress of novel strategies on immune-based therapy in relapsed or refractory diffuse large B-cell lymphoma, Experimental Hematology & Oncology

Chimeric antigen receptor T-cell therapies for lymphoma

CAR T-cell therapy in multiple myeloma: more room for improvement

Long-term outcomes following CAR T cell therapy: what we know so far

Frontiers Chimeric Antigen Receptor T-Cells: An Overview of Concepts, Applications, Limitations, and Proposed Solutions

The progress of novel strategies on immune-based therapy in relapsed or refractory diffuse large B-cell lymphoma, Experimental Hematology & Oncology

CAR T‑cell therapy for gastric cancer: Potential and perspective (Review)

Frontiers Mini review: Advances and challenges in CAR-T cell therapy: from early chimeric antigen receptors to future frontiers in oncology

CAR T-Cell Therapy for Cancer